Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Anaplastic Lymphoma Kinase (ALK) gene, as a tyrosine kinase closely related to tumors, can be activated by translocation or mutation. Abnormal expression such as gene mutation, rearrangement and amplification can activate cell signal transduction in the body. Pathway, which regulates the growth, differentiation and migration of tumors. Tyrosine kinases are kinases that enzymatically catalyze the transfer of gamma phosphate groups from adenosine triphosphate to target proteins. They can catalyze the phosphorylation of protein tyrosine residues on a variety of substrates, and play an important role in cell growth, proliferation, and differentiation. The main oncology indications for tyrosine kinase inhibitors (TKI) include solid tumors and leukemia.
LPI (LP Information)' newest research report, the “ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Industry Forecast” looks at past sales and reviews total world ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales in 2022, providing a comprehensive analysis by region and market sector of projected ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales for 2023 through 2029. With ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ALK Tyrosine Kinase Inhibitors (ALK-TKIs) industry.
This Insight Report provides a comprehensive analysis of the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ALK Tyrosine Kinase Inhibitors (ALK-TKIs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs).
The global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key ALK Tyrosine Kinase Inhibitors (ALK-TKIs) players cover Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding and Chugai Pharmaceutical Co, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Anaplastic Lymphoma Kinase (ALK) gene, as a tyrosine kinase closely related to tumors, can be activated by translocation or mutation. Abnormal expression such as gene mutation, rearrangement and amplification can activate cell signal transduction in the body. Pathway, which regulates the growth, differentiation and migration of tumors. Tyrosine kinases are kinases that enzymatically catalyze the transfer of gamma phosphate groups from adenosine triphosphate to target proteins. They can catalyze the phosphorylation of protein tyrosine residues on a variety of substrates, and play an important role in cell growth, proliferation, and differentiation. The main oncology indications for tyrosine kinase inhibitors (TKI) include solid tumors and leukemia.
LPI (LP Information)' newest research report, the “ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Industry Forecast” looks at past sales and reviews total world ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales in 2022, providing a comprehensive analysis by region and market sector of projected ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales for 2023 through 2029. With ALK Tyrosine Kinase Inhibitors (ALK-TKIs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ALK Tyrosine Kinase Inhibitors (ALK-TKIs) industry.
This Insight Report provides a comprehensive analysis of the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ALK Tyrosine Kinase Inhibitors (ALK-TKIs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs).
The global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key ALK Tyrosine Kinase Inhibitors (ALK-TKIs) players cover Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding and Chugai Pharmaceutical Co, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Crizotinib
- Alectinib
- Ceritinib
- Brigatinib
- Lorlatinib
- Ensartinib
- CT-707
- Leukemia
- Solid Tumor
- Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Nuvartis
- Takeda
- Betta Pharma
- Shouyao Holding
- Chugai Pharmaceutical Co
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2029
2.1.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Type
2.2.1 Crizotinib
2.2.2 Alectinib
2.2.3 Ceritinib
2.2.4 Brigatinib
2.2.5 Lorlatinib
2.2.6 Ensartinib
2.2.7 CT-707
2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type
2.3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
2.4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Application
2.4.1 Leukemia
2.4.2 Solid Tumor
2.4.3 Lung Cancer
2.4.4 Others
2.5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application
2.5.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
3 ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) MARKET SIZE BY PLAYER
3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Players
3.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2018-2023)
3.1.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Players (2018-2023)
3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) BY REGIONS
4.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Regions (2018-2023)
4.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023)
5.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
5.3 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023)
6.2 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
6.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) by Country (2018-2023)
7.2 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
7.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) by Region (2018-2023)
8.2 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
8.3 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) MARKET FORECAST
10.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Regions (2024-2029)
10.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Regions (2024-2029)
10.1.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Country (2024-2029)
10.2.1 United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.2 Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.3 Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.4 Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Region (2024-2029)
10.3.1 China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.2 Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.3 Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.4 Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.5 India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.6 Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Country (2024-2029)
10.4.1 Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.2 France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.3 UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.4 Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.5 Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Region (2024-2029)
10.5.1 Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.2 South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.3 Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.4 Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.5 GCC Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.6 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Type (2024-2029)
10.7 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.1.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Nuvartis
11.2.1 Nuvartis Company Information
11.2.2 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.2.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Nuvartis Main Business Overview
11.2.5 Nuvartis Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.3.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Betta Pharma
11.4.1 Betta Pharma Company Information
11.4.2 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.4.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Betta Pharma Main Business Overview
11.4.5 Betta Pharma Latest Developments
11.5 Shouyao Holding
11.5.1 Shouyao Holding Company Information
11.5.2 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.5.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Shouyao Holding Main Business Overview
11.5.5 Shouyao Holding Latest Developments
11.6 Chugai Pharmaceutical Co
11.6.1 Chugai Pharmaceutical Co Company Information
11.6.2 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.6.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Chugai Pharmaceutical Co Main Business Overview
11.6.5 Chugai Pharmaceutical Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2029
2.1.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Type
2.2.1 Crizotinib
2.2.2 Alectinib
2.2.3 Ceritinib
2.2.4 Brigatinib
2.2.5 Lorlatinib
2.2.6 Ensartinib
2.2.7 CT-707
2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type
2.3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
2.4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Segment by Application
2.4.1 Leukemia
2.4.2 Solid Tumor
2.4.3 Lung Cancer
2.4.4 Others
2.5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application
2.5.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
3 ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) MARKET SIZE BY PLAYER
3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Players
3.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2018-2023)
3.1.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Players (2018-2023)
3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) BY REGIONS
4.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Regions (2018-2023)
4.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
4.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023)
5.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
5.3 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023)
6.2 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
6.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) by Country (2018-2023)
7.2 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
7.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) by Region (2018-2023)
8.2 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023)
8.3 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALK TYROSINE KINASE INHIBITORS (ALK-TKIS) MARKET FORECAST
10.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Regions (2024-2029)
10.1.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Regions (2024-2029)
10.1.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.1.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast
10.2 Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Country (2024-2029)
10.2.1 United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.2 Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.3 Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.2.4 Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3 APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Region (2024-2029)
10.3.1 China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.2 Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.3 Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.4 Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.5 India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.3.6 Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Country (2024-2029)
10.4.1 Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.2 France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.3 UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.4 Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.4.5 Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Region (2024-2029)
10.5.1 Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.2 South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.3 Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.4 Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.5.5 GCC Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Forecast
10.6 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Type (2024-2029)
10.7 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.1.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Nuvartis
11.2.1 Nuvartis Company Information
11.2.2 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.2.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Nuvartis Main Business Overview
11.2.5 Nuvartis Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.3.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Betta Pharma
11.4.1 Betta Pharma Company Information
11.4.2 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.4.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Betta Pharma Main Business Overview
11.4.5 Betta Pharma Latest Developments
11.5 Shouyao Holding
11.5.1 Shouyao Holding Company Information
11.5.2 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.5.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Shouyao Holding Main Business Overview
11.5.5 Shouyao Holding Latest Developments
11.6 Chugai Pharmaceutical Co
11.6.1 Chugai Pharmaceutical Co Company Information
11.6.2 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
11.6.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Chugai Pharmaceutical Co Main Business Overview
11.6.5 Chugai Pharmaceutical Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Crizotinib
Table 3. Major Players of Alectinib
Table 4. Major Players of Ceritinib
Table 5. Major Players of Brigatinib
Table 6. Major Players of Lorlatinib
Table 7. Major Players of Ensartinib
Table 8. Major Players of CT-707
Table 9. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 12. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 15. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Player (2018-2023)
Table 17. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Key Players Head office and Products Offered
Table 18. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Regions (2018-2023)
Table 23. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country (2018-2023)
Table 27. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 29. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 31. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Table 33. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 35. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 37. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country (2018-2023)
Table 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 50. Key Market Challenges & Risks of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 51. Key Industry Trends of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 52. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Pfizer Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 57. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 58. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Nuvartis Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 62. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 63. Nuvartis Main Business
Table 64. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Nuvartis Latest Developments
Table 66. Takeda Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 67. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 68. Takeda Main Business
Table 69. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Takeda Latest Developments
Table 71. Betta Pharma Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 72. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 73. Betta Pharma Main Business
Table 74. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Betta Pharma Latest Developments
Table 76. Shouyao Holding Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 77. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 78. Shouyao Holding Main Business
Table 79. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Shouyao Holding Latest Developments
Table 81. Chugai Pharmaceutical Co Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 82. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 83. Chugai Pharmaceutical Co Main Business
Table 84. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Chugai Pharmaceutical Co Latest Developments
Table 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Crizotinib
Table 3. Major Players of Alectinib
Table 4. Major Players of Ceritinib
Table 5. Major Players of Brigatinib
Table 6. Major Players of Lorlatinib
Table 7. Major Players of Ensartinib
Table 8. Major Players of CT-707
Table 9. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 12. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 15. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Player (2018-2023)
Table 17. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Key Players Head office and Products Offered
Table 18. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Regions (2018-2023)
Table 23. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country (2018-2023)
Table 27. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 29. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 31. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Table 33. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 35. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 37. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country (2018-2023)
Table 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 50. Key Market Challenges & Risks of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 51. Key Industry Trends of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
Table 52. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Pfizer Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 57. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 58. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Nuvartis Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 62. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 63. Nuvartis Main Business
Table 64. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Nuvartis Latest Developments
Table 66. Takeda Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 67. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 68. Takeda Main Business
Table 69. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Takeda Latest Developments
Table 71. Betta Pharma Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 72. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 73. Betta Pharma Main Business
Table 74. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Betta Pharma Latest Developments
Table 76. Shouyao Holding Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 77. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 78. Shouyao Holding Main Business
Table 79. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Shouyao Holding Latest Developments
Table 81. Chugai Pharmaceutical Co Details, Company Type, ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Area Served and Its Competitors
Table 82. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Offered
Table 83. Chugai Pharmaceutical Co Main Business
Table 84. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Chugai Pharmaceutical Co Latest Developments
LIST OF FIGURES
Figure 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales Market Share by Country/Region (2022)
Figure 8. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type in 2022
Figure 10. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Leukemia
Figure 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Leukemia (2018-2023) & ($ Millions)
Figure 12. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Solid Tumor
Figure 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Solid Tumor (2018-2023) & ($ Millions)
Figure 14. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Lung Cancer
Figure 15. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 16. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Others
Figure 17. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Others (2018-2023) & ($ Millions)
Figure 18. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application in 2022
Figure 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Player in 2022
Figure 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 22. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 23. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 25. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Value Market Share by Country in 2022
Figure 26. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region in 2022
Figure 31. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type in 2022
Figure 32. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application in 2022
Figure 33. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country in 2022
Figure 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Figure 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Figure 42. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 56. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 57. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 59. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 60. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 63. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 64. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 65. Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 67. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 68. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 69. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 70. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 71. UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 72. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 73. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 74. Spain ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 77. Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 80. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales Market Share by Country/Region (2022)
Figure 8. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type in 2022
Figure 10. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Leukemia
Figure 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Leukemia (2018-2023) & ($ Millions)
Figure 12. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Solid Tumor
Figure 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Solid Tumor (2018-2023) & ($ Millions)
Figure 14. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Lung Cancer
Figure 15. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 16. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Others
Figure 17. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Others (2018-2023) & ($ Millions)
Figure 18. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application in 2022
Figure 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Player in 2022
Figure 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 22. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 23. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2018-2023 ($ Millions)
Figure 25. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Value Market Share by Country in 2022
Figure 26. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region in 2022
Figure 31. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type in 2022
Figure 32. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application in 2022
Figure 33. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Country in 2022
Figure 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Figure 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Figure 42. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 56. APAC ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 57. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 59. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 60. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 63. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 64. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 65. Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 67. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 68. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 69. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 70. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 71. UK ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 72. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 73. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 74. Spain ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 77. Israel ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size 2024-2029 ($ Millions)
Figure 80. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Market Share Forecast by Application (2024-2029)
